Current treatment status-Currently treated-Triple therapy Posts on Medivizor
Navigation Menu

Current treatment status-Currently treated-Triple therapy Posts on Medivizor

Examining the link between rituximab treatment, immune cell response and disease activity?

Examining the link between rituximab treatment, immune cell response and disease activity?

Posted by on Dec 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effect of rituximab (Rituxan) and levels of immune cells in patients with rheumatoid arthritis (RA).The authors concluded that certain immune cells are linked to disease activity in patients treated with rituximab. Measuring the levels of these cells could be used to determine if rituximab re-treatment is...

Read More

Is golimumab safe and effective in rheumatoid arthritis patients who have previously taken anti-TNF therapy?

Is golimumab safe and effective in rheumatoid arthritis patients who have previously taken anti-TNF therapy?

Posted by on Jun 21, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether golimumab (Simponi) is safe and effective in rheumatoid arthritis patients who have previously used anti-tumor necrosis factor therapy. Some background Anti-tumor necrosis factor (TNF) therapy (Humira, Enbrel, Remicade and Cimzia) is used to treat patients who have a severe form of rheumatoid arthritis...

Read More

Non-steroidal anti-inflammatory drugs in rheumatic patients: the impact on the gastrointestinal tract

Posted by on Jun 7, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined the frequency of gastrointestinal (digestive tract) events in at-risk rheumatic patients using non-steroidal anti-inflammatory drugs. Some background Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) are used to relieve pain in patients with rheumatic diseases. However, they can also cause...

Read More

Identifying rheumatoid arthritis patients that are suitable for a lower dose of anti-TNF alpha therapy

Posted by on Jun 1, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether a combination of clinical and ultrasound assessments could identify rheumatoid arthritis patients suitable for a lower dose of anti-TNF alpha therapy.  Some background Anti-TNF alpha therapy (Humira, Enbrel, Remicade and Cimzia) is used to treat patients who have a severe form of rheumatoid...

Read More

A new model to predict effectiveness of infliximab (Remicade) in rheumatoid arthritis patients

A new model to predict effectiveness of infliximab (Remicade) in rheumatoid arthritis patients

Posted by on Apr 21, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether doctors could predict the long term effectiveness of infliximab (Remicade) treatment for rheumatoid arthritis, based on early results at 3 months.  Some background Rheumatoid arthritis is an autoimmune disease, caused by the immune system attacking healthy tissue. Blocking the immune system...

Read More

Blood protein predicts future response to rheumatoid arthritis therapy

Blood protein predicts future response to rheumatoid arthritis therapy

Posted by on Apr 11, 2015 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated whether MRP8/14 protein levels can predict rheumatoid arthritis patient response to biologic drug treatment. Some background Rheumatoid arthritis is an inflammatory disease affecting the joints, the connections between bones. The goal of drug therapy is remission: a time when the disease is not active and...

Read More